– SWITZERLAND, Root – Novocure (NASDAQ: NVCR) today announced the election of Kristin Stafford to its Board of Directors.
“We look forward to welcoming Ms. Stafford to our board of directors. Her broad expertise in finance in the life sciences sector and experience with a leading funder of innovation across the biopharmaceutical industry will be valuable as our global organization prepares for future growth,” said Executive Chairman, William Doyle. Novocure’s. “
About Kristin Stafford
Kristin Stafford is SP, CAO for Royalty Pharma plc, a position she has held since December 2018. Before this position, she served as VP of Finance at Royalty Pharma and CFO of BioPharma Credit plc, an affiliate of Royal Pharma, from 2016 to 2018.
“With readouts from key clinical trials expected soon, this is an exciting time to join the board of Novocure,” said Kristin Stafford. “As Novocure grows, I look forward to helping the company execute on its strategy and deliver on its mission to extend survival in some of the most aggressive forms of cancer.”
Ms. Stafford is a Certified Public Accountant with a bachelor of science degree in business administration from Sonoma State University.
About Novocure
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for treating adult patients with glioblastoma, malignant pleural mesothelioma, and pleural mesothelioma. Novocure has ongoing or completed clinical studies investigating Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer.
Headquartered in Root, Switzerland, and with a growing global footprint, Novocure has regional operating centers in Portsmouth, New Hampshire, and Tokyo, as well as a research center in Haifa, Israel.
Source: https://www.novocure.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
